A microRNA survival signature (MiSS) for advanced ovarian cancer

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 444-450

  Shih, Karin K ^a   Qin, Li Xuan ^a   Tanner, Edward J ^a   Zhou, Qin ^a   Bisogna, Maria ^a   Dao, Fanny ^a   Olvera, Narciso ^a   Viale, Agnes ^a   Barakat, Richard R ^a   Levine, Douglas A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Advanced ovarian cancer; Gene expression; MicroRNA; Overall survival

Indexed keywords

MICRORNA;

ADULT; ADVANCED CANCER; AGE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SURVIVAL TIME;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SURVIVAL RATE;

EID: 79957516191     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.01.025     Document Type: Article

References (34)

1. American Cancer Society Cancer Facts & Figures2010 2010 American Cancer Society Atlanta
2. W. Hoskins Principles and Practice of Gynecologic Oncology 4th ed 2005 Lippincott Williams & Wilkins
3. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 1 Jul-Aug 2000 3 10
4. D. Spentzos, D.A. Levine, M.F. Ramoni, M. Joseph, X. Gu, and J. Boyd Gene expression signature with independent prognostic significance in epithelial ovarian cancer J Clin Oncol 22 23 Dec 1 2004 4700 4710
5. A. Berchuck, E.S. Iversen, J.M. Lancaster, J. Pittman, J. Luo, and P. Lee Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers Clin Cancer Res 11 10 May 15 2005 3686 3696 (Pubitemid 40685585)
6. R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, and S. Lade Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res 14 16 Aug 15 2008 5198 5208
7. T. Bonome, D.A. Levine, J. Shih, M. Randonovich, C.A. Pise-Masison, and F. Bogomolniy A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer Cancer Res 68 13 Jul 1 2008 5478 5486
8. L.C. Hartmann, K.H. Lu, G.P. Linette, W.A. Cliby, K.R. Kalli, and D. Gershenson Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy Clin Cancer Res 11 6 Mar 15 2005 2149 2155 (Pubitemid 40490171)
9. D. Spentzos, D.A. Levine, S. Kolia, H. Otu, J. Boyd, and T.A. Libermann Unique gene expression profile based on pathologic response in epithelial ovarian cancer J Clin Oncol 23 31 Nov 1 2005 7911 7918 (Pubitemid 46657390)
10. A.A. Jazaeri, C.S. Awtrey, G.V. Chandramouli, Y.E. Chuang, J. Khan, and C. Sotiriou Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers Clin Cancer Res 11 17 Sep 1 2005 6300 6310 (Pubitemid 41262961)
11. I. Bentwich, A. Avniel, Y. Karov, R. Aharonov, S. Gilad, and O. Barad Identification of hundreds of conserved and nonconserved human microRNAs Nat Genet 37 7 Jul 2005 766 770 (Pubitemid 41754896)
12. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 4 Apr 2006 259 269
13. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 2 Feb 2008 102 114
14. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, and P. Casalini MicroRNA signatures in human ovarian cancer Cancer Res 67 18 Sep 15 2007 8699 8707 (Pubitemid 47437445)
15. E.J. Nam, H. Yoon, S.W. Kim, H. Kim, Y.T. Kim, and J.H. Kim MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 9 May 1 2008 2690 2695
16. X. Hu, D.M. Macdonald, P.C. Huettner, Z. Feng, I.M. El Naqa, and J.K. Schwarz A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 114 3 Sep 2009 457 464
17. R. Eitan, M. Kushnir, G. Lithwick-Yanai, M.B. David, M. Hoshen, and M. Glezerman Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients Gynecol Oncol 114 2 Aug 2009 253 259
18. T. Boren, Y. Xiong, A. Hakam, R. Wenham, S. Apte, and G. Chan MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy Gynecol Oncol 113 2 May 2009 249 255
19. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2 Jan 15 2008 425 433 (Pubitemid 351380068)
20. S.F. Tavazoie, C. Alarcon, T. Oskarsson, D. Padua, Q. Wang, and P.D. Bos Endogenous human microRNAs that suppress breast cancer metastasis Nature 451 7175 Jan 10 2008 147 152
21. I. Vergote, G.J. Rustin, E.A. Eisenhauer, G.B. Kristensen, E. Pujade-Lauraine, and M.K. Parmar Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup J Natl Cancer Inst 92 18 Sep 20 2000 1534 1535
22. A. Grimson, K.K. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 27 1 Jul 6 2007 91 105 (Pubitemid 46991392)
23. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 1 Jan 14 2005 15 20 (Pubitemid 40094598)
24. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 7 Dec 26 2003 787 798 (Pubitemid 38058492)
25. G. Martin, K. Schouest, P. Kovvuru, and C. Spillane Prediction and validation of microRNA targets in animal genomes J Biosci 32 6 Sep 2007 1049 1052 (Pubitemid 47583865)
26. P. Maziere, and A.J. Enright Prediction of microRNA targets Drug Discov Today 12 11-12 Jun 2007 452 458 (Pubitemid 46795589)
27. N. Rajewsky microRNA target predictions in animals Nat Genet 38 Jun 2006 S8 S13 (Suppl)
28. A. Clauss, V. Ng, J. Liu, H. Piao, M. Russo, and N. Vena Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival Neoplasia 12 2 Feb 2010 161 172
29. P.A. Konstantinopoulos, E. Fountzilas, K. Pillay, L.F. Zerbini, T.A. Libermann, and S.A. Cannistra Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer BMC Med Genomics 1 2008 59
30. P. Celec Nuclear factor kappa B-molecular biomedicine: the next generation Biomed Pharmacother 58 6-7 Jul-Aug 2004 365 371
31. S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, and T. Ohta Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models Clin Cancer Res 10 22 Nov 15 2004 7645 7654 (Pubitemid 39557528)
32. J. Arts, P. Angibaud, A. Marien, W. Floren, B. Janssens, and P. King R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies Br J Cancer 97 10 Nov 19 2007 1344 1353 (Pubitemid 350114783)
33. D. Khabele, D.S. Son, A.K. Parl, G.L. Goldberg, L.H. Augenlicht, and J.M. Mariadason Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy Cancer Biol Ther 6 5 May 2007 795 801 (Pubitemid 47328364)
34. K.A. Strait, C.T. Warnick, C.D. Ford, B. Dabbas, E.H. Hammond, and S.J. Ilstrup Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad Mol Cancer Ther 4 4 Apr 2005 603 611 (Pubitemid 40601842)